Edition:
United Kingdom

ICON PLC (ICLR.OQ)

ICLR.OQ on NASDAQ Stock Exchange Global Select Market

121.22USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$121.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
107,671
52-wk High
$124.65
52-wk Low
$76.50

Chart for

About

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the... (more)

Overall

Beta: 0.42
Market Cap(Mil.): $6,550.90
Shares Outstanding(Mil.): 54.04
Dividend: --
Yield (%): --

Financials

  ICLR.OQ Industry Sector
P/E (TTM): 22.97 199.23 33.71
EPS (TTM): 5.28 -- --
ROI: 19.90 -0.66 13.09
ROE: 27.12 -2.84 14.92

BRIEF-ICON Announces Deal With Intel Allowing Integration Of The Intel Pharma Analytics Platform For Clinical Trials

* ICON ANNOUNCES AGREEMENT WITH INTEL ALLOWING INTEGRATION OF THE INTEL® PHARMA ANALYTICS PLATFORM FOR CLINICAL TRIALS

17 Apr 2018

BRIEF-Icon PLC Reports Qtrly EPS Of $1.43​

* ‍IN Q4 NET REVENUE GREW 4.6% YEAR ON YEAR TO $455 MILLION FROM $435 MILLION IN SAME QUARTER LAST YEAR​

15 Feb 2018

BRIEF-Icon Expects FY2018 Revenue In Range Of $1,870 Mln - $1,930 Mln

* - ‍FULL YEAR 2018 REVENUE GUIDANCE IN RANGE OF $1,870 - $1,930 MILLION, REPRESENTING GROWTH OF 7 - 10%​

09 Jan 2018

BRIEF-Icon Plc Q3 EPS $1.35

* Qtrly net revenue increased 4.8% to $440 million compared to same quarter last year​

26 Oct 2017

Earnings vs. Estimates